Abstract
Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Current Genomics
Title: Mouse Models of Human Hearing Disorders
Volume: 2 Issue: 1
Author(s): Kenneth R. Johnson
Affiliation:
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Abstract: Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Export Options
About this article
Cite this article as:
Johnson R. Kenneth, Mouse Models of Human Hearing Disorders, Current Genomics 2001; 2 (1) . https://dx.doi.org/10.2174/1389202013351156
DOI https://dx.doi.org/10.2174/1389202013351156 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Exploring Sterol and Lipid Biology in the Functional Genomic Era
Current Pharmaceutical Biotechnology Cardiovascular Involvement in Pediatric Systemic Autoimmune Diseases: The Emerging Role of Noninvasive Cardiovascular Imaging
Inflammation & Allergy - Drug Targets (Discontinued) Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Novel Antiviral Strategies to Combat Human Arenavirus Infections
Current Molecular Medicine Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews Chaperone Therapy: New Molecular Therapy for Protein Misfolding Diseases with Brain Dysfunction
Current Bioinformatics Prognostic Implications of Genetics in Cardiovascular Disease
Current Pharmacogenomics Coronary Artery Ectasia-A Review of Current Literature
Current Cardiology Reviews Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Biodegradable and Bioabsorbable Stents
Current Pharmaceutical Design Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome
Current Drug Safety Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design